Literature DB >> 11719200

Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins.

W G Annaert1, C Esselens, V Baert, C Boeve, G Snellings, P Cupers, K Craessaerts, B De Strooper.   

Abstract

The carboxyl terminus of presenilin 1 and 2 (PS1 and PS2) binds to the neuron-specific cell adhesion molecule telencephalin (TLN) in the brain. PS1 deficiency results in the abnormal accumulation of TLN in a yet unidentified intracellular compartment. The first transmembrane domain and carboxyl terminus of PS1 form a binding pocket with the transmembrane domain of TLN. Remarkably, APP binds to the same regions via part of its transmembrane domain encompassing the critical residues mutated in familial Alzheimer's disease. Our data surprisingly indicate a spatial dissociation between the binding site and the proposed catalytic site near the critical aspartates in PSs. They provide important experimental evidence to support a ring structure model for PS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719200     DOI: 10.1016/s0896-6273(01)00512-8

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  59 in total

1.  Mutation analysis of the presenilin 1 N-terminal domain reveals a broad spectrum of gamma-secretase activity toward amyloid precursor protein and other substrates.

Authors:  Ping Gong; Kulandaivelu S Vetrivel; Phuong D Nguyen; Xavier Meckler; Haipeng Cheng; Maria Z Kounnas; Steven L Wagner; Angèle T Parent; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  Syntaxin 5 interacts with presenilin holoproteins, but not with their N- or C-terminal fragments, and affects beta-amyloid peptide production.

Authors:  Kei Suga; Takami Tomiyama; Hiroshi Mori; Kimio Akagawa
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

3.  Inhibition of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1.

Authors:  Lujia Zhou; Lucia Chávez-Gutiérrez; Katrijn Bockstael; Ragna Sannerud; Wim Annaert; Patrick C May; Eric Karran; Bart De Strooper
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

4.  Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1.

Authors:  Orly Lazarov; Gerardo A Morfini; Gustavo Pigino; Archana Gadadhar; Xiangjun Chen; John Robinson; Hanson Ho; Scott T Brady; Sangram S Sisodia
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

5.  ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.

Authors:  Thomas Tousseyn; Amantha Thathiah; Ellen Jorissen; Tim Raemaekers; Uwe Konietzko; Karina Reiss; Elke Maes; An Snellinx; Lutgarde Serneels; Omar Nyabi; Wim Annaert; Paul Saftig; Dieter Hartmann; Bart De Strooper
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

Review 6.  Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer's disease.

Authors:  Daniel R Dries; Gang Yu
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

7.  Functional and topological analysis of Pen-2, the fourth subunit of the gamma-secretase complex.

Authors:  Leen Bammens; Lucía Chávez-Gutiérrez; Alexandra Tolia; An Zwijsen; Bart De Strooper
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 8.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

Review 9.  Toward the structure of presenilin/γ-secretase and presenilin homologs.

Authors:  Michael S Wolfe
Journal:  Biochim Biophys Acta       Date:  2013-12

10.  Allosteric modulation of PS1/gamma-secretase conformation correlates with amyloid beta(42/40) ratio.

Authors:  Kengo Uemura; Christina M Lill; Xuejing Li; Jessica A Peters; Alexander Ivanov; Zhanyun Fan; Bart DeStrooper; Brian J Bacskai; Bradley T Hyman; Oksana Berezovska
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.